Abstract: A collet structure may include a holder, a plate and an absorption member. The holder may include a shank and a vacuum provider. The shank may include a first magnet. The vacuum provider may be positioned over the shank. The vacuum provider may include at least one first vacuum hole configured to transfer vacuum, which may be supplied from the outside, to a space under the shank. The plate may have a size substantially the same as a size of the shank. The plate may include a plurality of second vacuum holes connected directly and indirectly to the first vacuum hole. The absorption member may be attached to the plate. The absorption member may include a plurality of third vacuum holes connected directly and indirectly to the plurality of second vacuum holes.

Abstract: In a display device including unfoldable areas and a foldable area between the unfoldable areas, the display device includes: a window; a display panel under the window; a fingerprint detection sensor configured to generate signals for fingerprint recognition in a direction toward the display panel in any one of the unfoldable areas; a first support member supporting the display panel under the display panel and between the display panel and the fingerprint detection sensor; a second support member supporting the display panel under the first support member and having an opening overlapping the fingerprint detection sensor; and a reinforcing member overlapping the opening of the second support member and between the first support member and the fingerprint detection sensor, wherein the reinforcing member includes glass.

Abstract: A method for manufacturing a display device includes providing a preliminary display device including a display module, an optical layer disposed on a first surface of the display module, a first protective film disposed on the optical layer, a second protective film disposed on a second surface of the display module, a first adhesive layer disposed between the optical layer and the first protective film, and a second adhesive layer disposed between the second protective film and the display module, forming a mask layer on the first protective film by irradiating a first laser light on the first protective film along a first processing line, and cutting the preliminary display device at an outer periphery of the second processing line by irradiating a second laser light on the first protective film along a second processing line positioned at an outer periphery of the first processing line.

Abstract: A display device and a method of fabricating the display device are provided. The display device includes a display panel comprising a surface where images are displayed, and an opposite surface, and a polymer film layer disposed on the opposite surface of the display panel, wherein the polymer film layer comprises grooves recessed toward the display panel.

Abstract: A display device is provided.

Abstract: A display device is provided.

Abstract: A display device is provided.

Abstract: A display device is provided.

Abstract: A mobile communication terminal including: a window glass provided on a front side of a terminal main body; a speaker hole formed on an edge of the terminal main body corresponding to an edge of an outer portion of the window glass, exposed to the outside, and formed to correspond to a speaker provided in the terminal main body; and a sensor connected to the speaker, and sensing a direction in which the terminal main body is slanted, wherein the sensor controls the speaker to open or close the speaker hole according to the direction in which the terminal main body is slanted.

Abstract: A touch screen panel in which an occurrence of a scratch at intersections of coupling patterns respectively coupling first sensing cells and second sensing cells to each other in a first direction and in a second direction is prevented. The touch screen panel includes a transparent substrate, sensing patterns formed on a surface of the transparent substrate. The sensing patterns include first sensing cells disposed along a first direction, second sensing cells disposed between the first sensing cells along a second direction intersecting the first direction, first coupling patterns coupling the first sensing cells to each other in the first direction, second coupling patterns coupling the second sensing cells to each other in the second direction, and an insulating layer disposed between the first coupling patterns and the second coupling patterns at intersections of the first coupling patterns and the second coupling patterns.

Abstract: A mobile communication terminal including: a window glass provided on a front side of a terminal main body; a speaker hole formed on an edge of the terminal main body corresponding to an edge of an outer portion of the window glass, exposed to the outside, and formed to correspond to a speaker provided in the terminal main body; and a sensor connected to the speaker, and sensing a direction in which the terminal main body is slanted, wherein the sensor controls the speaker to open or close the speaker hole according to the direction in which the terminal main body is slanted.

Abstract: A touch panel comprises a substrate and at least one touch pad positioned on the substrate and having an uneven surface. Each touch pad contacts the substrate, and comprises a plurality of first sub-touch pads arranged in a first direction, a first connector connecting adjacent first sub-touch pads to each other, a plurality of second sub-touch pads arranged in a second direction crossing the first direction, a second connector positioned so as to correspond to the first connector and connecting adjacent second sub-touch pads to each other, and an insulating layer positioned between the first connector and the second connector. A manufacturing method of the touch panel comprises preparing a substrate, and forming at least one touch pad on the substrate, each touch pad having an uneven surface.

Abstract: The present invention relates to an agent for preventing and treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) associated with BPH and a relaxant for relaxing urethral smooth muscle or prostatic smooth muscle comprising a pyrazolopyrimidinone compound as an effective ingredient. The agent in accordance with the present invention can provide nitric oxides by inhibiting the activity of PDE-5 that decomposes c-GMP, and the provided nitric oxides relax the urethral smooth muscle or the prostatic smooth muscle to lower the intraurethral pressure (IUP), thus treating BPH and LUTS associated with BPH. Furthermore, the time required for reaching a maximum blood concentration is shorter and the half-life is longer than the other PDE-5 inhibitors, thus reducing the frequency of administration. Moreover, the agent of the invention causing few side effects can be efficiently used as a safe drug.

Abstract: A touch screen panel in which an occurrence of a scratch at intersections of coupling patterns respectively coupling first sensing cells and second sensing cells to each other in a first direction and in a second direction is prevented. The touch screen panel includes a transparent substrate, sensing patterns formed on a surface of the transparent substrate. The sensing patterns include first sensing cells disposed along a first direction, second sensing cells disposed between the first sensing cells along a second direction intersecting the first direction, first coupling patterns coupling the first sensing cells to each other in the first direction, second coupling patterns coupling the second sensing cells to each other in the second direction, and an insulating layer disposed between the first coupling patterns and the second coupling patterns at intersections of the first coupling patterns and the second coupling patterns.

Abstract: The present invention relates to an agent for preventing and treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) associated with BPH and a relaxant for relaxing urethral smooth muscle or prostatic smooth muscle comprising a pyrazolopyrimidinone compound as an effective ingredient. The agent in accordance with the present invention can provide nitric oxides by inhibiting the activity of PDE-5 that decomposes c-GMP, and the provided nitric oxides relax the urethral smooth muscle or the prostatic smooth muscle to lower the intraurethral pressure (IUP), thus treating BPH and LUTS associated with BPH. Furthermore, the time required for reaching a maximum blood concentration is shorter and the half-life is longer than the other PDE-5 inhibitors, thus reducing the frequency of administration. Moreover, the agent of the invention causing few side effects can be efficiently used as a safe drug.